# A Multi-center, Double-blind, Randomized Study, Comparing Clindamycin Phosphate Vaginal Cream 2% (Watson Laboratories, Inc.) to Clindesse® (Ther-Rx™, Clindamyin Phosphate Vaginal Cream 2%) and Both Active Treatments to a Placebo Control in the Treatment of Bacterial Vaginosis in Non-pregnant Women

> **NCT02210689** · PHASE3 · COMPLETED · sponsor: **Actavis Inc.** · enrollment: 604 (actual)

## Conditions studied

- BACTERIAL VAGINOSIS
- Signs and Symptoms to be Evaluated and Recorded Include
- Vaginal Discharge Color, Odor, and Consistency
- Vulvovaginal Itching and Irritation (Subjective) Absent, Mild, Moderate, or Severe
- Vulvovaginal Inflammation (Objective) Absent, Mild, Moderate, or Severe

## Interventions

- **DRUG:** clindamycin phosphate vaginal cream 2%
- **OTHER:** placebo

## Key facts

- **NCT ID:** NCT02210689
- **Lead sponsor:** Actavis Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-01
- **Primary completion:** 2014-10
- **Final completion:** 2014-12
- **Target enrollment:** 604 (ACTUAL)
- **Last updated:** 2020-01-28

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02210689

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02210689, "A Multi-center, Double-blind, Randomized Study, Comparing Clindamycin Phosphate Vaginal Cream 2% (Watson Laboratories, Inc.) to Clindesse® (Ther-Rx™, Clindamyin Phosphate Vaginal Cream 2%) and Both Active Treatments to a Placebo Control in the Treatment of Bacterial Vaginosis in Non-pregnant Women". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT02210689. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*